Healthcare, Pharma & Life Sciences

National Medical Fellowships Marks 80 Years, $50M in Scholarships

Chicago – September 20, 2026 -- National Medical Fellowships (NMF) has awarded more than $50 million in scholarships and supported over 32,000 scholars across all 50 states since its founding in 1946, the organization announced ahead of its 80th anniversary celebration this October in Chicago, where its mission began.

NMF marks eight decades of funding medical education pathways

The nonprofit's support has extended beyond scholarships to mentorship, career development, service-learning programs, and clinical research leadership training for aspiring and current health professionals. Alumni from the program have gone on to work as physicians, educators, and health care leaders serving communities nationwide.

LIMS Market to Hit $5.84B by 2031 as Labs Shift to Cloud, AI

Image
LIMS Market to Hit $5.84B by 2031 as Labs Shift to Cloud, AI

Delray Beach – September 20, 2026 -- The global Laboratory Information Management System (LIMS) market is projected to grow from USD 3.26 billion in 2026 to USD 5.84 billion by 2031, a compound annual growth rate of 12.4%, according to MarketsandMarkets.

Rising test volumes force labs to digitize workflows

The US Centers for Disease Control and Prevention estimates that healthcare professionals order more than 14 billion laboratory tests annually across over 266,000 CLIA-certified laboratories nationwide. In India, the RMLIMS platform recorded complete blood count testing rise from 236,289 to 331,541 procedures between 2023 and 2025, while molecular testing volumes climbed from 728 to 1,236 over the same period.

Koning Breast CT System Wins Australian TGA Approval

Image
Koning Breast CT System Wins Australian TGA Approval

Norcross, Ga. – September 20, 2026 -- Koning Health's Breast CT System, the CBCT 1000, has been added to the Australian Register of Therapeutic Goods (ARTG No. 531059), clearing the device for commercial supply in Australia.

TGA approves device inclusion on September 8, 2026

The Therapeutic Goods Administration granted the ARTG listing on September 8, 2026, allowing Koning Health to begin commercial supply in Australia subject to regulatory conditions tied to the inclusion.

Brisbane Radiology becomes first Australian buyer of the system

Brisbane Radiology has committed to purchasing the Koning Breast CT System, making it the first provider in the country to adopt the technology. Clinical Director Jacqui Milne said the approval marks a milestone for breast imaging in Australia and expects it to create new opportunities for patients and providers nationwide.

AAE Wins Four PRSA Chicago Skyline Awards for Misinformation Campaigns

Image
AAE Wins Four PRSA Chicago Skyline Awards for Misinformation Campaigns

Chicago – September 20, 2026 -- The American Association of Endodontists (AAE) won four honors at the 2026 PRSA Chicago Skyline Awards for communications work combating dental health misinformation and promoting evidence-based endodontic care.

AAE secures four distinct award categories at the Sept. 17 gala

The winning initiatives were "Truth vs. Trends: How One Association Combats Trending Fear-Based Information," the "Worth Saving Campaign in 2025," "Combating Root Canal Misinformation Through Evidence-Based Public Education," and "Worth Saving: Reaching Digital-First Audiences Through Integrated Social Media Education." The awards were presented at Venue West in Chicago as part of PRSA Chicago's premier public relations competition for the greater Chicago area.

NAVER D2SF Backs ImpriMed's $10M Round for AI Cancer Diagnostics

Seoul – September 20, 2026 -- NAVER D2SF, the in-house corporate venture arm of NAVER, has joined a $10 million Series A2 bridge round for Silicon Valley-based precision medicine company ImpriMed, backing its push toward U.S. regulatory clearance and Asian market expansion.

ImpriMed targets FDA clearance and CLIA certification by Q1 2027 for its blood cancer platform

The company is preparing to commercialize diagnostic products for blood cancers and blood infection in the United States, having already established business partnerships with major U.S. hospitals. ImpriMed's xCellSense platform keeps patient-derived cancer cells viable outside the body for extended periods, allowing evaluation of drug sensitivity alongside genomic, immunophenotypic and clinical data. The company's AI models are trained on more than 3.5 million data points combining real-world data with functional cell analysis.

MCW Inaugurates Dr. Shekar Kurpad as Seventh President, CEO

Image
MCW Inaugurates Dr. Shekar Kurpad as Seventh President, CEO

Milwaukee – September 20, 2026 -- The Medical College of Wisconsin (MCW) formally inaugurated Shekar N. Kurpad, MD, PhD, as its seventh President and Chief Executive Officer on September 17 at the Marcus Performing Arts Center in downtown Milwaukee, marking a leadership transition at the nation's third-largest private medical school.

Kurpad succeeds a 16-year CEO tenure at one of the country's top-performing academic medical centers

Dr. Kurpad, a neurosurgeon with more than two decades of service at MCW, takes over from John R. Raymond, Sr., MD, who led the institution as President and CEO for 16 years.

Gallup-Pivotal Survey: 51% of U.S. Women Report Negative Care Experiences

Image
Gallup-Pivotal Survey: 51% of U.S. Women Report Negative Care Experiences

Washington – September 20, 2026 -- More than half of U.S. women, 51%, report at least one negative healthcare experience in the past five years, compared with 39% of men, according to a new Gallup-Pivotal survey released Sept. 18, 2026.

The research, conducted by Gallup in partnership with Pivotal, the organization founded by Melinda French Gates, finds that 42% of women say their health has prevented them from doing everything they wanted to do in life over the past five years. Fifty-four percent report at least one health-related impact on family life or relationships, 42% on work or career, and 32% on community participation.

China Inbound Medical Tourism Jumps 73.6% as Jiahui Cites WTO Forum

Geneva – September 20, 2026 -- China's leading hospitals serving international patients recorded 1.28 million international patient visits in 2025, up 73.6% from three years earlier, Dr. John K. Hsiang, Chairman of Jiahui Health's Executive Committee, said at the WTO Public Forum 2026.

Inbound patient volumes surge past 1.28 million visits in 2025

Of the 1.28 million total visits, 413,000 were made by patients who travelled to China specifically for medical care, according to data cited by Dr. Hsiang. At Jiahui Health, overseas patient inquiries nearly doubled year on year in the first half of 2026. Dr. Hsiang was the sole Chinese healthcare representative invited to the forum's "Health Without Borders" session on medical tourism in services trade.

Andelyn Begins Commercial Manufacturing of FDA-Approved Gene Therapy FAYUVI

Image
Andelyn Begins Commercial Manufacturing of FDA-Approved Gene Therapy FAYUVI

Columbus, Ohio – September 20, 2026 -- Andelyn Biosciences has begun commercial manufacturing of FAYUVI (rebisufligene etisparvovec-hopf) at its Columbus facility, marking the first FDA-approved gene therapy produced using the company's AAV Curator Platform process. The therapy, developed by Ultragenyx Pharmaceutical Inc., recently received U.S. Food and Drug Administration approval for treating Sanfilippo syndrome type A, also known as mucopolysaccharidosis type IIIA (MPS IIIA).

FDA clears gene therapy for a rare, fatal childhood disease

MPS IIIA is a rare lysosomal storage disorder that drives rapid neurodegeneration starting in early childhood, primarily affecting the central nervous system. The disease impacts an estimated 3,000 to 5,000 patients worldwide, with a median life expectancy of 15 years.

Carestream Launches STARVIEW Digital Radiography System for Routine Imaging

Image
Carestream Launches STARVIEW Digital Radiography System for Routine Imaging

Shanghai – September 20, 2026 -- Carestream Healthcare International has launched the STARVIEW Digital Radiography System, a floor-mounted DR room built for routine radiographic imaging.

STARVIEW targets facilities upgrading from film, CR or aging DR systems

The system is designed to serve healthcare facilities introducing a first DR room, replacing legacy film-based or computed radiography equipment, or expanding routine-imaging capacity. Carestream built the platform around three pillars: fully digital operation, ease of adoption and scalability for future growth.